Diabetes, Vol 44, Issue 10 1176-1179, Copyright © 1995 by American Diabetes Association

ARTICLES

Late progression to diabetes and evidence for chronic beta-cell autoimmunity in identical twins of patients with type I diabetes

CF Verge, R Gianani, L Yu, M Pietropaolo, T Smith, RA Jackson, JS Soeldner and GS Eisenbarth
Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver 80262, USA.

Previous studies suggest that after 6 years of discordance, identical twin pairs rarely become concordant for type I diabetes. With up to 39 years of follow-up from the onset of diabetes in the index twin, we determined how many discordant twins have evidence of beta-cell autoimmunity and how many develop overt diabetes. We longitudinally followed 23 pairs of identical twins (or triplets) that were selected from a total group of 30 pairs because they were discordant for type I diabetes when first ascertained. Seven developed diabetes after 3, 3, 7, 8, 9, 31 and 36 years of discordance. By survival analysis, the concordance after 10 years from the onset of diabetes in the index twin was estimated as 23% (95% confidence interval, 5-40%), increasing to 38% (95% confidence interval, 8-69%) after 31 years. Among 16 twins remaining nondiabetic at last follow-up (8-39 years of discordance), 12 were assessed with serial intravenous glucose tolerance tests and a total of 407 measurements by radioassay of antibodies against three defined autoantigens (glutamic acid decarboxylase, insulin, and the recently cloned molecule ICA512). Two-thirds (8 of 12) had evidence of beta-cell autoimmunity (persistently positive autoantibody levels) and/or first-phase insulin release less than the 1st percentile of control subjects. In summary, identical twins may develop diabetes after a prolonged period of discordance and approximately two-thirds of long-term discordant twins have evidence of persistent beta-cell autoimmunity and/or beta-cell damage. The concordance for beta-cell autoimmunity, therefore, is much higher than for overt diabetes.(ABSTRACT TRUNCATED AT 250 WORDS)
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				S. Onengut-Gumuscu, J. H. Buckner, and P. Concannon A Haplotype-Based Analysis of the PTPN22 Locus in Type 1 Diabetes. Diabetes, October 1, 2006; 55(10): 2883 - 2889. [Abstract] [Full Text] [PDF]

				N. A. Sherry, E. B. Tsai, and K. C. Herold Natural History of {beta}-Cell Function in Type 1 Diabetes Diabetes, December 1, 2005; 54(suppl_2): S32 - S39. [Abstract] [Full Text] [PDF]

				L. Poirot, C. Benoist, and D. Mathis Natural killer cells distinguish innocuous and destructive forms of pancreatic islet autoimmunity PNAS, May 25, 2004; 101(21): 8102 - 8107. [Abstract] [Full Text] [PDF]

				V. Hyttinen, J. Kaprio, L. Kinnunen, M. Koskenvuo, and J. Tuomilehto Genetic Liability of Type 1 Diabetes and the Onset Age Among 22,650 Young Finnish Twin Pairs: A Nationwide Follow-Up Study Diabetes, April 1, 2003; 52(4): 1052 - 1055. [Abstract] [Full Text] [PDF]

				O. Kanagawa, A. Militech, and B. A. Vaupel Regulation of Diabetes Development by Regulatory T Cells in Pancreatic Islet Antigen-Specific TCR Transgenic Nonobese Diabetic Mice J. Immunol., June 15, 2002; 168(12): 6159 - 6164. [Abstract] [Full Text] [PDF]

				K. A. Metcalfe, G. A. Hitman, R. E. Rowe, M. Hawa, X. Huang, T. Stewart, and R. D. G. Leslie Concordance for Type 1 Diabetes in Identical Twins Is Affected by Insulin Genotype Diabetes Care, May 1, 2001; 24(5): 838 - 842. [Abstract] [Full Text]

				J. C. Jaume, J. Guo, D. L. Pauls, M. Zakarija, J. M. McKenzie, J. A. Egeland, C. L. Burek, N. R. Rose, W. H. Hoffman, B. Rapoport, et al. Evidence for Genetic Transmission of Thyroid Peroxidase Autoantibody Epitopic "Fingerprints" J. Clin. Endocrinol. Metab., April 1, 1999; 84(4): 1424 - 1431. [Abstract] [Full Text]

				M. J Redondo, M. Rewers, L. Yu, S. Garg, C. C Pilcher, R. B Elliott, and G. S Eisenbarth Genetic determination of islet cell autoimmunity in monozygotic twin, dizygotic twin, and non-twin siblings of patients with type 1 diabetes: prospective twin study BMJ, March 13, 1999; 318(7185): 698 - 702. [Abstract] [Full Text]

				J. S Petersen, K. O Kyvik, P. J Bingley, E. A M Gale, A. Green, T. Dyrberg, and H. Beck-Nielsen Population based study of prevalence of islet cell autoantibodies in monozygotic and dizygotic Danish twin pairs with insulin dependent diabetes mellitus BMJ, May 31, 1997; 314(7094): 1575 - 1575. [Abstract] [Full Text]

				R. H. Slover and G. S. Eisenbarth Prevention of Type I Diabetes and Recurrent {beta}-Cell Destruction of Transplanted Islets Endocr. Rev., April 1, 1997; 18(2): 241 - 258. [Abstract] [Full Text]